This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The Lipid Research Clinics Coronary Primary Prevention Trial

Ernst J. Schaefer, MD; Stefania Lamon-Fava, MD, PhD; Jennifer L. Jenner, MS; Judith R. McNamara, MT; Jose M. Ordovas, PhD; C. Edward Davis, PhD; Jeffrey M. Abolafia, MA; Kenneth Lippel, PhD; Robert I. Levy, MD

JAMA. 1994;271(13):999-1003.

Abstract
Objective.
—To examine the relationship between elevated levels of lipoprotein(a) [Lp(a)] and coronary heart disease (CHD) risk in a prospective study.

Design.
—Nested case-control study. The cohort consisted of participants in the Lipid Research Clinics Coronary Primary Prevention Trial.

Setting.
—Lipid research clinics.

Participants.
—The Lipid Research Clinics Coronary Primary Prevention Trial participants (n=3806) were men, aged 35 to 59 years, with plasma cholesterol levels of 6.85 mmol/L (265 mg/dL) or greater, low-density lipoprotein cholesterol levels of 4.91 mmol/L (190 mg/dL) or greater, and triglyceride levels less than 3.39 mmol/L. Subjects were randomly assigned to either cholestyramine or placebo treatment. The Lp(a) levels were measured in plasma samples obtained prior to randomization in 233 cases (participants who developed CHD in the course of the study) and 390 matched CHD-free controls. A total of 96.95% of the subjects were white, 2.25% were black, and 0.80% were of other race.

Main Outcome Measure.
—Coronary heart disease (either fatal or nonfatal) events during a follow-up of 7 to 10 years.

Results.
—The Lp(a) levels were significantly higher (21%) in cases than in controls (23.7 mg/dL [0.59 mmol/L and 19.5 mg/dL [0.49 mmol/L], respectively; P<.02). This difference was still statistically significant (P<.01) after controlling for age, body mass index, cigarette smoking, blood pressure, low-density lipoprotein cholesterol level, and high-density lipoprotein cholesterol level. When subjects were divided by treatment, both cholestyramine-treated and placebo-treated CHD subjects had Lp(a) levels 20% to 22% greater than their matched controls. However, possibly because of smaller sample sizes, these differences were no longer statistically significant.

Conclusions.
—Our data are consistent with the concept that an elevated Lp(a) level is an independent risk factor for CHD in hypercholesterolemic white men.

(JAMA. 1994;271:999-1003)

Author Affiliations
From the Lipid Metabolism Laboratory, US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Mass (Drs Schaefer, Lamon-Fava, and Ordovas and Mss Jenner and McNamara), Department of Biostatistics, University of North Carolina, Chapel Hill (Dr Davis and Mr Abolafia), and Division of Heart and Vascular Diseases, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Dr Lippel and Levy). Dr Levy is now with Wyeth-Ayerst Research, Philadelphia, Pa.

Footnotes
Reprint requests to Lipid Metabolism Laboratory, USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St, Boston, MA 02111 (Dr Schaefer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force
Helfand et al.
ANN INTERN MED 2009;151:496-507.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
The Emerging Risk Factors Collaboration
JAMA 2009;302:412-423.
ABSTRACT | FULL TEXT  

Dietary Fructose and Glucose Differentially Affect Lipid and Glucose Homeostasis
Schaefer et al.
J. Nutr. 2009;139:1257S-1262S.
ABSTRACT | FULL TEXT  

Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study
Tsimikas et al.
Circulation 2009;119:1711-1719.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Levels and Risk of Future Coronary Heart Disease: Large-Scale Prospective Data
Bennet et al.
Arch Intern Med 2008;168:598-608.
ABSTRACT | FULL TEXT  

Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik et al.
JAMA 2006;296:1363-1370.
ABSTRACT | FULL TEXT  

Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]
Rubin et al.
J. Lipid Res. 2006;47:982-989.
ABSTRACT | FULL TEXT  

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
Tsimikas et al.
J Am Coll Cardiol 2006;47:C19-C31.
ABSTRACT | FULL TEXT  

Inflammation, Atherosclerosis, and Aspects of Insulin Action
Bloomgarden
Diabetes Care 2005;28:2312-2319.
FULL TEXT  

Conditional Risk Factors for Atherosclerosis
Kullo and Ballantyne
Mayo Clin Proc. 2005;80:219-230.
ABSTRACT  

Lipoprotein(a): An Elusive Cardiovascular Risk Factor
Berglund and Ramakrishnan
Arterioscler. Thromb. Vasc. Bio. 2004;24:2219-2226.
ABSTRACT | FULL TEXT  

Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study
Rifai et al.
Clin. Chem. 2004;50:1364-1371.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Is an Independent Risk Factor for Peripheral Arterial Disease in Chinese Type 2 Diabetic Patients in Taiwan
Tseng
Diabetes Care 2004;27:517-521.
ABSTRACT | FULL TEXT  

The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease
Muntner et al.
ANN INTERN MED 2004;140:9-17.
ABSTRACT | FULL TEXT  

Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Ariyo et al.
NEJM 2003;349:2108-2115.
ABSTRACT | FULL TEXT  

Black Tea Consumption Reduces Total and LDL Cholesterol in Mildly Hypercholesterolemic Adults
Davies et al.
J. Nutr. 2003;133:3298S-3302.
ABSTRACT | FULL TEXT  

Lack of genetic linkage evidence for a trans-acting factor having a large effect on plasma lipoprotein[a] levels in African Americans
Barkley et al.
J. Lipid Res. 2003;44:1301-1305.
ABSTRACT | FULL TEXT  

Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes
Bermudez et al.
Am. J. Clin. Nutr. 2002;76:1214-1221.
ABSTRACT | FULL TEXT  

Simvastatin Lowers C-Reactive Protein Within 14 Days: An Effect Independent of Low-Density Lipoprotein Cholesterol Reduction
Plenge et al.
Circulation 2002;106:1447-1452.
ABSTRACT | FULL TEXT  

Elevated Serum Lipoprotein(a) Level Is an Independent Marker of Severity of Thoracic Aortic Atherosclerosis*
Peltier et al.
Chest 2002;121:1589-1594.
ABSTRACT | FULL TEXT  

Fibrinolytic Parameters and Lipoprotein(a) in Young Women with Myocardial Infarction
Salobir et al.
ANGIOLOGY 2002;53:157-163.
ABSTRACT  

Risk factors for coronary heart disease: implications of gender
Roeters van Lennep et al.
Cardiovasc Res 2002;53:538-549.
ABSTRACT | FULL TEXT  

Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians
Rubin et al.
J. Lipid Res. 2002;43:234-244.
ABSTRACT | FULL TEXT  

Lipoproteins, nutrition, and heart disease
Schaefer
Am. J. Clin. Nutr. 2002;75:191-212.
ABSTRACT | FULL TEXT  

Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population
Paultre et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:141-146.
ABSTRACT | FULL TEXT  

Fluorescence-based, Nonradioactive Method for Efficient Detection of the Pentanucleotide Repeat (TTTTA)n Polymorphism in the Apolipoprotein(a) Gene
Rubin et al.
Clin. Chem. 2001;47:1758-1762.
ABSTRACT | FULL TEXT  

Instability of Lipoprotein(a) in Plasma Stored at -70 {degrees}C : Effects of Concentration, Apolipoprotein(a) Genotype, and Donor Cardiovascular Disease
Simo et al.
Clin. Chem. 2001;47:1673-1678.
ABSTRACT | FULL TEXT  

Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina
Bogaty et al.
Circulation 2001;103:3062-3068.
ABSTRACT | FULL TEXT  

Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui et al.
Arch Intern Med 2001;161:1413-1419.
ABSTRACT | FULL TEXT  

Lipoprotein(a) changes during natural menstrual cycle and ovarian stimulation with recombinant and highly purified urinary FSH
Ricci et al.
Hum Reprod 2001;16:449-456.
ABSTRACT | FULL TEXT  

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk
von Eckardstein et al.
J Am Coll Cardiol 2001;37:434-439.
ABSTRACT | FULL TEXT  

High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men
Paultre et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:2619-2624.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and Coronary Heart Disease : Meta-Analysis of Prospective Studies
Danesh et al.
Circulation 2000;102:1082-1085.
ABSTRACT | FULL TEXT  

Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency: A Randomized, Controlled Clinical Trial
Sesmilo et al.
ANN INTERN MED 2000;133:111-122.
ABSTRACT | FULL TEXT  

Estrogen and Progestin, Lipoprotein(a), and the Risk of Recurrent Coronary Heart Disease Events After Menopause
Shlipak et al.
JAMA 2000;283:1845-1852.
ABSTRACT | FULL TEXT  

Substituting Walnuts for Monounsaturated Fat Improves the Serum Lipid Profile of Hypercholesterolemic Men and Women: A Randomized Crossover Trial
Zambon et al.
ANN INTERN MED 2000;132:538-546.
ABSTRACT | FULL TEXT  

Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women
Nishino et al.
J Am Coll Cardiol 2000;35:314-320.
ABSTRACT | FULL TEXT  

Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Foody et al.
Arterioscler. Thromb. Vasc. Bio. 2000;20:493-499.
ABSTRACT | FULL TEXT  

Lipoprotein (a) and Genetic Polymorphisms of Clotting Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Are Risk Factors of Spontaneous Ischemic Stroke in Childhood
Nowak-Gottl et al.
Blood 1999;94:3678-3682.
ABSTRACT | FULL TEXT  

Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Harjai
ANN INTERN MED 1999;131:376-386.
ABSTRACT | FULL TEXT  

Increased Lipoprotein(a) Is an Important Risk Factor for Venous Thromboembolism in Childhood
Nowak-Gottl et al.
Circulation 1999;100:743-748.
ABSTRACT | FULL TEXT  

Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Seman et al.
Clin. Chem. 1999;45:1039-1046.
ABSTRACT | FULL TEXT  

Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker
ANN INTERN MED 1999;130:933-937.
ABSTRACT | FULL TEXT  

Proteoglycans Contribution to Association of Lp(a) and LDL With Smooth Muscle Cell Extracellular Matrix
Lundstam et al.
Arterioscler. Thromb. Vasc. Bio. 1999;19:1162-1167.
ABSTRACT | FULL TEXT  

The Low Molecular Weight Apo(a) Phenotype Is an Independent Predictor for Coronary Artery Disease in Hemodialysis Patients: A ProspectiveFollow-Up
KRONENBERG et al.
J. Am. Soc. Nephrol. 1999;10:1027-1036.
ABSTRACT | FULL TEXT  

Forecasting Patient Outcomes in the Management of Hyperlipidemia
Brier et al.
Arch Intern Med 1999;159:569-575.
ABSTRACT | FULL TEXT  

Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
Nilausen and Meinertz
Am. J. Clin. Nutr. 1999;69:419-425.
ABSTRACT | FULL TEXT  

Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies
Craig et al.
Clin. Chem. 1998;44:2301-2306.
ABSTRACT | FULL TEXT  

Maximizing the Cost-effectiveness of Lipid-Lowering Therapy
Jacobson et al.
Arch Intern Med 1998;158:1977-1989.
ABSTRACT | FULL TEXT  

Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
Su et al.
J. Clin. Endocrinol. Metab. 1998;83:3267-3276.
ABSTRACT | FULL TEXT  

Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein
Jialal
Clin. Chem. 1998;44:1827-1832.
ABSTRACT | FULL TEXT  

Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
McNamara et al.
Clin. Chem. 1998;44:1224-1232.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy et al.
Circulation 1998;97:1876-1887.
FULL TEXT  

Alcohol Withdrawal–Induced Change in Lipoprotein(a) : Association With the Growth Hormone/Insulin-like Growth Factor-I (IGF-I)/IGF-Binding Protein-1 (IGFBP-1) Axis
Paassilta et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:650-654.
ABSTRACT | FULL TEXT  

Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects : The Delta Study, Protocol 1
Ginsberg et al.
Arterioscler. Thromb. Vasc. Bio. 1998;18:441-449.
ABSTRACT | FULL TEXT  

Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene
Wade et al.
J. Biol. Chem. 1997;272:30387-30399.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
Hopkins et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:2783-2792.
ABSTRACT | FULL TEXT  

Apolipoprotein(a) Induces Monocyte Chemotactic Activity in Human Vascular Endothelial Cells
Poon et al.
Circulation 1997;96:2514-2519.
ABSTRACT | FULL TEXT  

Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a)
McCormick et al.
J. Biol. Chem. 1997;272:23616-23622.
ABSTRACT | FULL TEXT  

Plasma Lipoprotein (a) Levels in Men and Women Consuming Diets Enriched in Saturated, Cis-, or Trans-Monounsaturated Fatty Acids
Clevidence et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1657-1661.
ABSTRACT | FULL TEXT  

Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women
Tuck et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1822-1829.
ABSTRACT | FULL TEXT  

Lipoprotein Lp(a) Excess and Coronary Heart Disease
Stein and Rosenson
Arch Intern Med 1997;157:1170-1176.
ABSTRACT  

A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants
Wild et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:239-245.
ABSTRACT | FULL TEXT  

Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women
Orth-Gomer et al.
Circulation 1997;95:329-334.
ABSTRACT | FULL TEXT  

Lipoprotein(a) Assembly: Quantitative Assessment of the Role of Apo(a) Kringle IV Types 2-10 in Particle Formation
Gabel et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1559-1567.
ABSTRACT | FULL TEXT  

Lipoprotein(a) in Stored Plasma Samples and the Ravages of Time: Why Epidemiological Studies Might Fail
Kronenberg et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:1568-1572.
ABSTRACT | FULL TEXT  

Beyond LDL Cholesterol Reduction
Superko
Circulation 1996;94:2351-2354.
FULL TEXT  

Serum Lipoprotein(a) Level Is Related to Thrombin Generation and Spontaneous Intermittent Coronary Occlusion in Patients With Acute Myocardial Infarction
Haider et al.
Circulation 1996;94:2072-2076.
ABSTRACT | FULL TEXT  

Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger: A Prospective Study
Bostom et al.
JAMA 1996;276:544-548.
ABSTRACT  

Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess
Rosenson
Arch Intern Med 1996;156:1278-1284.
ABSTRACT  

Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease
Kraft et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:713-719.
ABSTRACT | FULL TEXT  

Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women
Guetta and Cannon
Circulation 1996;93:1928-1937.
FULL TEXT  

Changes in Lp(a) Lipoprotein and Lipid Levels After Cessation of Female Sex Hormone Production and Estrogen Replacement Therapy
Kim et al.
Arch Intern Med 1996;156:500-504.
ABSTRACT  

Race and Gender Differences in the Association of Lp(a) With Carotid Artery Wall Thickness : The Atherosclerosis Risk in Communities (ARIC) Study
Schreiner et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:471-478.
ABSTRACT | FULL TEXT  

Plasma Lipoprotein(a) Levels in Subjects Attending a Metabolic Ward : Discrimination Between Individuals With and Without a History of IschemicStroke
Margaglione et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:120-128.
ABSTRACT | FULL TEXT  

Lp(a) Levels and Atherosclerotic Vascular Disease in a Sample of Patients With Familial Hypercholesterolemia Sharing the Same Gene Defect
Carmena et al.
Arterioscler. Thromb. Vasc. Bio. 1996;16:129-136.
ABSTRACT | FULL TEXT  

Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher et al.
JAMA 1995;274:1771-1774.
ABSTRACT  

Lipoprotein(a) Concentration and Risk of Atherothrombotic Disease-Reply
Ridker et al.
JAMA 1995;274:1198-1199.
ABSTRACT  

Inhibitors for the In Vitro Assembly of Lp(a)
Frank et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1774-1780.
ABSTRACT | FULL TEXT  

Apo(a) Phenotypes and Lp(a) Concentrations in Offspring of Men With and Without Myocardial Infarction : The EARS Study
Klausen et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1001-1008.
ABSTRACT | FULL TEXT  

Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation
Ferrieres et al.
Circulation 1995;92:290-295.
ABSTRACT | FULL TEXT  

No Association Between Plasma Lipoprotein(a) Concentrations and the Presence or Absence of Coronary Atherosclerosis in African-Americans
Moliterno et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:850-855.
ABSTRACT | FULL TEXT  

Plasma Concentration of Lipoprotein(a) and the Risk of Future Stroke
Ridker et al.
JAMA 1995;273:1269-1273.
ABSTRACT  

Identification of Two Functionally Distinct Lysine-binding Sites in Kringle 37 and in Kringles 32-36 of Human Apolipoprotein(a)
Ernst et al.
J. Biol. Chem. 1995;270:6227-6234.
ABSTRACT | FULL TEXT  

C/T Polymorphism in the 5' Untranslated Region of the Apolipoprotein(a) Gene Introduces an Upstream ATG and Reduces In Vitro Translation
Zysow et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:58-64.
ABSTRACT | FULL TEXT  

Lipoprotein(a) in Coronary Heart Disease: Is It a Risk Factor After All?
Gurewich and Mittleman
JAMA 1994;271:1025-1026.
ABSTRACT